Odyssey Health, Inc.
ODYY
$0.0087
$0.000.00%
| Weiss Ratings | ODYY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | E | |||
| Rating Factors | ODYY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Very Weak | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | ODYY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.18 | |||
| Price History | ODYY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -16.35% | |||
| 30-Day Total Return | -25.00% | |||
| 60-Day Total Return | -57.56% | |||
| 90-Day Total Return | -54.21% | |||
| Year to Date Total Return | -65.20% | |||
| 1-Year Total Return | -82.60% | |||
| 2-Year Total Return | -90.84% | |||
| 3-Year Total Return | -98.15% | |||
| 5-Year Total Return | -99.59% | |||
| 52-Week High % Change | -87.57% | |||
| 52-Week Low % Change | 1.16% | |||
| Price | ODYY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.07 | |||
| 52-Week Low Price | $0.01 | |||
| 52-Week Low Price (Date) | Mar 06, 2025 | |||
| 52-Week High Price (Date) | May 20, 2024 | |||
| Valuation | ODYY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 841.37K | |||
| Enterprise Value | 2.80M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.15 | |||
| Earnings Per Share Growth | -292.76% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -0.13 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.01 | |||
| Enterprise Value/EBITDA (TTM) | -3.21 | |||
| Enterprise Value/EBIT | -3.21 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | ODYY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 104.71M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | ODYY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 702 780 6559 | |||
| Address | 2300 West Sahara Avenue Las Vegas, NV 89102 | |||
| Website | www.odysseyhealthinc.com | |||
| Country | United States | |||
| Year Founded | 2014 | |||
| Profitability | ODYY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | ODYY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -7.61% | |||
| Return on Equity | -- | |||
| Income Statement | ODYY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -871.10K | |||
| EBIT (TTM) | -871.90K | |||
| Net Income (TTM) | -14.82M | |||
| Net Income Avl. to Common (TTM) | -14.82M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | -101.66% | |||
| EPS Diluted (TTM) | -0.15 | |||
| EPS Diluted Growth (Q YOY) | -101.79% | |||
| Balance Sheet | ODYY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 7.20K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 108.40K | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -6.46M | |||
| Current Ratio (Q) | 0.016 | |||
| Book Value Per Share (Q) | -$0.07 | |||
| Total Assets (Q) | 266.90K | |||
| Total Current Liabilities (Q) | 6.73M | |||
| Total Debt (Q) | 1.97M | |||
| Total Liabilities (Q) | 6.73M | |||
| Total Common Equity (Q) | -6.46M | |||
| Cash Flow | ODYY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 0.00 | |||
| Cash from Financing (TTM) | 384.00K | |||
| Net Change in Cash (TTM) | -158.90K | |||
| Levered Free Cash Flow (TTM) | -63.80K | |||
| Cash from Operations (TTM) | -542.90K | |||
